Integrated transplant Ottr is now part of CareDx, Inc., positioning it within a broader transplant surveillance ecosystem. This creates cross-selling opportunities for CareDx’s genomics and noninvasive diagnostics solutions to OTTR’s 60+ transplant centers and international clients.

Expansion potential OTTR serves over 200 programs across the US and Canada with extensions into the UK, Saudi Arabia, and Australia. A sales focus can target expansions in these markets where international regulatory models require compliant workflow and data management.

Clinical workflow OTTR’s strength lies in automating administrative tasks and improving data accuracy for transplant teams. This aligns with CareDx’s push for surveillance solutions, offering a comprehensive platform upgrade that reduces manual work and enhances compliance.

Growth signals With revenue in the tens of millions and a history of partnerships and acquisitions, there is appetite for scalable, integrated software solutions that can grow with transplant programs, suggesting upsell opportunities to add modules or analytics features.

Tech and data Existing tech stack focuses on web-based, patient-tracking and reporting workflows. There is room to propose modernization through cloud-native components, enhanced analytics, and interoperability with CareDx’s genomics platform to strengthen end-to-end patient care.